Gilead Sciences (MIL:1GILD) Total Debt per Share : €0.00 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Gilead Sciences Total Debt per Share?

€0.00 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Gilead Sciences's Total Debt Per Share for the quarter that ended in Mar. 2024 was €0.00.

Gilead Sciences Total Debt per Share Historical Data

The historical data trend for Gilead Sciences's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Total Debt per Share Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Debt per Share

Get a 7-Day Free Trial

17.48

20.58

18.84

19.10

18.39

Gilead Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Debt per Share	Get a 7-Day Free Trial															18.89	18.69	18.77	18.39	-

Gilead Sciences Total Debt per Share Calculation

Gilead Sciences's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(21,264	+	1,649)	/	1,246
	=	18.39

Gilead Sciences's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0	+	0)	/	1,247
	=	0.00

Gilead Sciences Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences (MIL:1GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (MIL:1GILD) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GISd:UK 0QYQ:UK GIS:Germany GILD34:Brazil GILD:Austria GILD:Argentina

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Gilead Sciences (MIL:1GILD) Headlines

No Headlines